Home / Inspections / 1304042

FDA Inspection 1304042 — Octapharma plasma Inc.

Octapharma plasma Inc. — FEI 1073111

The FDA completed an inspection of Octapharma plasma Inc. on January 21, 2026 in Columbia, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 21, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Columbia, SC (United States)

Facility

Other inspections at this facility

  • 1043453 (NAI Thu Mar 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 897806 (NAI Mon Sep 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 771601 (VAI Wed Feb 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 676545 (NAI Thu Aug 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources